GE HEALTHCARE TO OPEN BIOTECHNOLOGY MANUFACTURING CENTER IN THE U.K.

GE Healthcare (www.gehealthcare.com) announced the opening of a biotechnology manufacturing center at the Stevenage Bioscience Catalyst (SBC) Open Innovation Campus, in Stevenage, U.K. (photo). In the first half of 2019, the center will start producing a fiber-based purification platform, which has the potential to significantly improve efficiency in the purification steps of manufacturing biopharmaceuticals, gene therapies and viral vectors. The fiber-based purification platform comprises material with a unique proprietary structure. This has the potential to significantly improve process speed, flexibility and robustness during purification, a key step in the manufacturing of biopharmaceuticals.  Additional products will also be produced at the center to serve both laboratory and clinical applications.